	Subsequent-line Systemic Therapy for Metastatic or Recurrent Penile Cancer: A Systematic Review of Efficacy, Toxicity, and Outcomes. Eur Urol Focus Garaz R, Ziada M, Crozier J, Pang KH, Alnajjar HM, Alifrangis C, Tsaur I, Muneer A. PMID: 41519649 [PubMed - as supplied by publisher]
	Cross-omics interpretable neural network for discovery of molecular markers in prostate cancer. Comput Biol Chem Chen X, Yi S, Yuemaierabola A, Liu Y, He L, Ma J, Guo W, Sun G. PMID: 41518989 [PubMed - as supplied by publisher]
	Hereditary renal cell carcinoma surveillance protocols: a review of the literature and proposed recommendations. Fam Cancer Miranda M, Ferreira C, Fernandes M, Lopes F, Ye A, Sousa AB, Costa L, Palma Dos Reis J, Palmela Leitão T. PMID: 41518461 [PubMed - indexed for MEDLINE]
	Lesion distribution and prognosis of renal cell carcinoma bone metastasis: A novel evaluation model based on random survival forests. Int J Cancer Huang Z, Yu L, Zhang X, Li Q, Liu S, Xu T. PMID: 41518076 [PubMed - as supplied by publisher]
	An update on the treatment paradigm for non-clear cell renal cell carcinoma. Expert Rev Clin Pharmacol Rametta A, Crippa N, Rota S, Gusmaroli E, Stellato M, Verzoni E, Nuzzo A, Claps M, Guadalupi V, Procopio G. PMID: 41517842 [PubMed - as supplied by publisher]
	Optimizing Ki-67 and E-Cadherin Thresholds for Improved Grade and Stage Classification in Urothelial Bladder Cancer. J Clin Med Harsanyi S, Novakova ZV, Neuschlova L, Galbavy S, Danisovic L, Ziaran S, Bevizova K. PMID: 41517587 [PubMed]
	Identification of a Muscle-Invasive Bladder Carcinoma Molecular Subtype of Poor Responders to Neoadjuvant Chemotherapy and High Expression of Targetable Biomarkers. Int J Mol Sci Trilla-Fuertes L, Pedregosa-Barbas J, García-Fernández E, Zambrana F, Martínez-Salas I, Gajate P, Becerril-Gómez F, Lalanda-Delgado P, Dittmann A, López-Vacas R, Kunz L, Rubio G, Nieto-Torrero S, Pertejo A, González-Peramato P, Fresno Vara JÁ, Gámez-Pozo A, Pinto-Marín Á. PMID: 41516353 [PubMed - indexed for MEDLINE]
	Conceptualization of an Ex Vivo Organ Culture (EVOC) Model for Human Seminoma: A Pilot Study. Int J Mol Sci Demyashkin G, Shchekin V, Parshenkov M, Shegay P, Kaprin A. PMID: 41516325 [PubMed - indexed for MEDLINE]
	Novel Mixed Cancer-Cell Models Designed to Capture Inter-Patient Tumor Heterogeneity for Accurate Evaluation of Drug Combinations. Int J Mol Sci Jena S, Kim DC, Lee AM, Zhang W, Zhan K, Elmorsi RM, Li Y, Dehm SM, Huang RS. PMID: 41516287 [PubMed - indexed for MEDLINE]
	The Diagnostic Performance of a Four-Gene Digital Droplet PCR Panel for Urine Liquid Biopsy in Urothelial Bladder Cancer. Diagnostics (Basel) Jain M, Tivtikyan A, Kislyakov D, Rakhmatullin T, Kamalov D, Kokarev V, Vorobeva L, Samokhodskaya L, Zvereva M, Kamalov A. PMID: 41515564 [PubMed]
	Cutibacterium acnes: An Emerging Prostate Cancer Pathogen. Biology (Basel) Brajdic L, Reed EK, Pearson HB, Brown HL. PMID: 41514871 [PubMed]
	Targeting Cancer-Associated Fibroblasts in Prostate Cancer: Recent Advances and Therapeutic Opportunities. Cancers (Basel) Chen P, Chen J, Zhan P, Ye X, Zhao L, Zhang Z, Zuo J, Shi H, Li X, Wu S, Fu Y, Wang H, Fu S. PMID: 41514658 [PubMed]
	Neoadjuvant Therapies for Prostate Cancer-Current Paradigms and Future Directions. Cancers (Basel) Sandhu K, Al-Khanaty A, Hennes D, Chen D, Dinneen E, Delgado C, Lawrentschuk N, Eapen RS, Murphy DG, Perera M. PMID: 41514578 [PubMed]
	New Insights into Prostate Cancer Susceptibility in European Caucasians: A Systematic Review and Meta-Analysis of CYP3A4 Pharmacogene. Cancers (Basel) Pagoni M, Cava C, Tsangaris GT, Siannis F, Drakoulis N. PMID: 41514571 [PubMed]
	Clear Cell Renal Cell Carcinoma Metastasis to the Thyroid: A Narrative Review of the Literature. Cancers (Basel) Samaras MG, Pouliakis A, Skaretzos K, Boutas I, Kontogeorgi A, Dimas DT, Ieronimaki AI, Zanelli M, Palicelli A, Zizzo M, Broggi G, Caltabiano R, Salzano S, Koufopoulos NI. PMID: 41514570 [PubMed]
	Systemic Chemotherapy in Penile Squamous Cell Carcinoma: Mechanisms, Clinical Applications, and Evidence-Based Regimens. Cancers (Basel) Grudzi, Czajkowski M, Dolny M, Matuszewski M, Wierzbicki PM, Rybarczyk A, Hakenberg OW. PMID: 41514559 [PubMed]
	The Olive Phenolic S-(-)-Hydroxyoleocanthal Attenuates Neuroendocrine Prostate Cancer via Modulation of EPHA3-Centered Oncogenic Network. Cancers (Basel) Tarun MTI, Ebrahim HY, El Sayed KA. PMID: 41514539 [PubMed]
	Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma. Cancer Cell Int Dai H, Zhang X, Yin L, Chen H, Liu K, Li J, Li H, Sheng L, Wu H, Wang J, He S, Li Q, Lv Y. PMID: 41514260 [PubMed - as supplied by publisher]
	Functional footprints of homologous recombination deficiency in prostate cancer revealed by ctDNA fragmentation and transcription factor accessibility. Br J Cancer Vlachos G, Moser T, Lazzeri I, Moser MJ, Glawitch L, Bauernhofer ET, Eberhard A, Beichler C, Sadeghi H, Blatterer J, Kühberger S, Monsberger N, Terbuch A, Kashofer K, Geigl JB, Bauernhofer T, Heitzer E. PMID: 41514011 [PubMed - as supplied by publisher]
	A novel prognostic nomogram for elderly renal cell carcinoma patients with lung metastases. Sci Rep Li Z, Liu M, Wang X, Wang F. PMID: 41513983 [PubMed - as supplied by publisher]

Articles 1 - 20 / 175137

Page 1 of 8757



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy